Taiho Oncology, Inc.
Volker Wacheck is the Senior Vice President at Taiho Oncology, Inc., overseeing the global clinical development programs for the oncology portfolio. Previously, Volker held roles at Eli Lilly and Company as the Senior Medical Director and Global Medical Lead for various oncology products. With a background in clinical pharmacology and oncology, Wacheck has extensive experience in leading research teams and developing innovative therapies for cancer treatment.
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com